Trial intelligence / Profile preview

Levothyroxine treatment versus follow-up only in pregnant women with subclinical hypothyroidism

IRCT20180314039091N1Phase 3Completed

Sponsor
Zanjan University of Medical Sciences
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: pregnancy loss. Started Apr 2018; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on IRCT20180314039091N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180314039091N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call